Moxifloxacin Ethyl Ester
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

1403836-23-6Moxifloxacin Ethyl Ester

● 在庫あり

カタログ番号:VE008859
CAS番号:1403836-23-6
分子式:C23H28FN3O4
分子量:429.49 g/mol

に関する追加情報 CAS 1403836-23-6

親薬物

Moxifloxacin

IUPAC名

ethyl 1-cyclopropyl-6-fluoro-7-((4aS, 7aS)-hexahydro-1H-pyrrolo[3, 4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylate

同義語

1-Cyclopropyl-6-fluoro-1, 4-dihydro-8-methoxy-7-[(4aS, 7aS)-octahydro-6H-pyrrolo[3, 4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester; ethyl 1-Cyclopropyl-6-fluoro-7-((4aS, 7aS)-hexahydro-1H-pyrrolo[3, 4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylate

説明

An artificial fluoroquinolone antibiotic is moxifloxacin. The medication was created by Bayer AG. Moxifloxacin inhibits the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which causes it to have bactericidal effects. Involved in the replication, transcription, and repair of bacterial DNA, DNA gyrase is a crucial enzyme. A crucial portion of the partitioning of the chromosomal DNA during bacterial cell division is known to be played by the enzyme topoisomerase IV. The antibacterial drug moxifloxacin works by attaching to an enzyme called DNA gyrase and preventing bacteria from unwinding one DNA double helix into two, which is necessary for DNA replication. Notably, the drug's affinity for bacterial DNA gyrase is 100 times greater than for mammalian DNA gyrase.

References

Tulkens, Paul M., et al. “Moxifloxacin Safety.” Drugs in R&D, vol. 12, no. 2, June 2012, pp. 71–100, https://doi.org/10.2165/11634300-000000000-00000. ‌

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url